SUPERDONOR
LIVE

Serial Number

97196369

Owner

MYBIOTICS PHARMA LTD

Attorney

Yael Rouach Cabilly

Filing Date

Dec 30, 2021

Add to watchlist:

No watchlists yet
View on USPTO

SUPERDONOR Trademark

Serial Number: 97196369 • Registration: 7153599

SUPERDONOR is a trademark filed by MYBIOTICS PHARMA LTD on December 30, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

MYBIOTICS PHARMA LTD (4 trademarks)

2 Ilan Ramon

Entity Type: 16

Trademark Details

Filing Date

December 30, 2021

Registration Date

September 5, 2023

Published for Opposition

June 20, 2023

Goods & Services

Dietary supplements; food supplements; nutritional supplements; dietary and nutritional supplements; dietary food supplemental drinks; dietary food supplements; dietary supplement drink mixes in the nature of vitamin and mineral beverages; dietary supplements for animals; dietary supplements for human consumption; dietary supplements with a cosmetic effect; powdered food supplements; powdered nutritional supplements; probiotic supplements; probiotic dietary supplements; probiotic preparations for medical use; sedatives; antifungal medication in the nature of antifungal preparations; medicines for alleviating constipation; pharmaceutical preparations for treating allergies; pharmaceutical preparations for the treatment of hormonal disorders; medicines for treating intestinal disorders; preparations for treating colds; burn relief medication; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical antitussive-cold preparations; non-prescription medicines, namely, medicinal preparations in the nature of pills, tablets, capsules, caplets, liquid drops, sachets, oral liquids, suspensions, liquids, semi-solids, creams, syrups, ointments, lotions, gels, sprays, emulations, oils, pessaries, suppositories, granules and films for the treatment of cardiovascular disorders, antibiotic associated diarrhea, gastrointestinal disorders, neurological disorders, ophthalmological disorders, neurodegenerative disorders, cognitive impairment, damaged skin and tissue, pulmonary disorders, for supporting oncology treatments, for the prevention and treatment of allergies, for the prevention and treatment of bacterial vaginosis and vaginal related women health disorders, for the prevention and treatment of urogenital related health disorders, for alleviating constipation, for the prevention and treatment of dysbiosis, for enrichment of beneficial bacteria; medicines for dental purposes; medicines for veterinary purposes namely, anti-infective products for veterinary use, veterinary pharmaceutical preparations and substances for the treatment of cardiovascular disorders, antibiotic associated diarrhea, gastrointestinal disorders, neurological disorders, ophthalmological disorders, neurodegenerative disorders, cognitive impairment, damaged skin and tissue, pulmonary disorders, for supporting oncology treatments, for the prevention and treatment of allergies, for the prevention and treatment of vaginal related health disorders, for the prevention and treatment of urogenital related health disorders, for alleviating constipation, for the prevention and treatment of dysbiosis, for enrichment of beneficial bacteria; pain relief medication; decongestant capsules; herbal medicines, namely, medicinal herbal preparations, herbal pharmaceutical preparations and herbal substances for the treatment of cardiovascular disorders, antibiotic associated diarrhea, gastrointestinal disorders, neurological disorders, ophthalmological disorders, neurodegenerative disorders, cognitive impairment, damaged skin and tissue, pulmonary disorders, for supporting oncology treatments, for the prevention and treatment of allergies, for the prevention and treatment of vaginal related health disorders, for the prevention and treatment of urogenital related health disorders, for alleviating constipation, for the prevention and treatment of dysbiosis, for enrichment of beneficial bacteria; antihypertensives; antitussives; diarrhea medication; antiflatulants ; antiemetics; antivirals; pharmaceutical preparations for the treatment of allergic rhinitis; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; medicines for treating gastrointestinal diseases

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 5, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 5, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 20, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jun 20, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 31, 2023 NONP
ELECTRONIC RECORD REVIEW COMPLETE
May 15, 2023 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
May 12, 2023 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
May 9, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 10, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 9, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 9, 2023 TROA
ASSIGNED TO EXAMINER
Feb 21, 2023 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 11, 2022 GNRN
NON-FINAL ACTION E-MAILED
Oct 11, 2022 GNRT
NON-FINAL ACTION WRITTEN
Oct 11, 2022 CNRT
ASSIGNED TO EXAMINER
Oct 5, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 6, 2022 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 5, 2022 NWOS
NEW APPLICATION ENTERED
Jan 3, 2022 NWAP